Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up

Annals of Oncology

Volumn 19, Issue SUPPL. 2, 2008, Pages

  Pacini, F ^a,c   Castagna, M G ^a,c   Brilli, L ^a,c   Jost, L ^b,c  

^a UNIVERSITY OF SIENA   (Italy)

^b Kantonsspital Bruderholz ^*  (Switzerland)

^c ESMO HEAD OFFICE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; IODINE 131;

ARTICLE; ASPIRATION BIOPSY; CALCITONIN BLOOD LEVEL; CANCER INCIDENCE; CANCER MORTALITY; CANCER STAGING; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; THYROID CANCER; THYROID MEDULLARY CARCINOMA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; INCIDENCE; PATHOLOGY; THYROID TUMOR; TUMOR RECURRENCE;

FOLLOW-UP STUDIES; HUMANS; INCIDENCE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; THYROID NEOPLASMS;

EID: 45149097980     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn115     Document Type: Article

References (17)

1. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006; 295: 2164-2167.
2. Leenhardt L, Bȩrnier MO, Boin-Pineau MH et al. Advances in diagnostic practices affect thyroid cancer incidence in France. Eur J Endocrinol 2004; 150: 133-139.
3. Levi F, Randimbison L, Te VC et al. Thyroid cancer in Vaud, Switzerland: an update. Thyroid 2002; 12: 163-168.
4. Pacini F, Burroni L, Ciuoli C et al. Managment of thyroid nodules: A clinicophatological evidence-based approach. Eur J Nucl Med Mol Imaging 2004; 31: 1443-1449.
5. Cap J, Ryska A, Rehorkova P et al. Sensitivity and specificity of the fine needle aspiration biopsy of the thyroid: Clinical point of view. Clin Endocrinol 1999; 51: 509-515.
6. Pacini F, Schlumberger M, Dralle H et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium, Eur J Endocrinol 2006; 154: 787-803.
7. Cooper DS, Doherty GM, Haugen BR et al. The American Thyroid Association Guidelines Taskforce Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006; 16: 109-142.
8. Elisei R, Bottici V, Luchetti F et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: Experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 2004; 89: 163-168.
9. Pacini F, Ladenson PW, Schlumberger M et al. Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: Results of an international, randomized, controlled study. J Clin Endocrinol 2006; 91: 926-932.
10. Wittekind C, Compton CC, Greene FL et al. TNM residual tumor classification revisited. Cancer 2002; 94: 2511-2516.
11. Mazzaferri EL, Jhiang SM. Long term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994; 97: 418-428.
12. Schlumberger M, Borget I, De Pouvourville G et al. Recombinant human thyroid-stimulating hormone: Use in papillary and follicular thyroid cancer. Horm Res 2007; 67 (Suppl 1): 132-142.
13. Pacini F, Capezzone M, Elisei R et al. Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. J Clin Endocrinol Metab 2002; 87: 1499-1501.
14. Cailleux AF, Baudin E, Travagli JP et al. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? J Clin Endocrinol Metab. 2000; 85: 175-178.
15. Biondi B, Filetti S, Schlumberger M. Thyroid-hormone therapy and thyroid cancer: A reassessment. Nat Clin Pract Endocrinol Metab 2005; 1: 32-40.
16. Pacini F, Cetani F, Miccoli P et al. Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine. World J Surg 1994; 18: 600-604.
17. Schlumberger M, Challeton C, De Vathaire F et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 1996; 37: 598-605.